Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
Hematologic Oncology Update
00:00
The Face of AML in Older Adults With AML
HMA Venetoclax HMA has changed the face of AML in older patients. It's so much more effective as you'll see momentarily based on the update of the VialeA trial that I think there's a greater willingness to treat an AML patient. But it still takes some resources to treat an older adult with AML with AS of Ven because it is mal-suppressive.
Transcript
Play full episode
